Navigation Links
Acne Drug Found To Cause More Harm than Good

Study have now shown that the acne drug isotretinoin has been found to have more dangerous side effects than what has been so far thought// , even though it is an effective medication for the treatment.

Isotretinoin, which is commonly sold as Accutane in the US and as Roaccutane in UK, and other such similar brand names, is known to clear up severe acne and prevent scarring, in conditions where other drugs have failed. But in a new study the researchers have shown that it also can cause miscarriages, premature births and birth defects such as mental retardation and cleft lip.

Explaining that though the drug is known to cure almost acne almost 89% of the patients, the researchers have said that it can also raise levels of blood fats and liver enzymes. They further explained that these increased liver enzymes might be a sign that the liver is getting damaged, while increased levels of cholesterol and triglyceride blood fats are usually linked to heart disease.

The study, which had been published in the August issue of the Archives of Dermatology, was conducted by Dr Lee Zane, from the University of California at San Francisco, and colleagues, who looked into the frequency of abnormal laboratory blood tests in 13,772 people between the ages 13 to 50 who had undertaken treatment with isotretinoin between 1995 and 2002.

They reported in their study that among the patients who had shown normal readings previously, 44% developed high triglycerides, while 31% of them had high cholesterol, and 11% high liver enzymes. The researchers also explained that they found that these irregularities were generally reversible after the patients stopped taking the medication.

It has been reported that in the patient care info that is usually provided with Accutane does specify that 25% of patients are known to experience raised triglycerides, and 15% elevated liver enzymes. Explaining that further research would be needed to gau ge the side effect risks, the researchers concluded their writing in the journal stating, “In clinical practice, laboratory abnormalities should be evaluated in the clinical context of the individual patient.

Related medicine news :

1. Fluoride Found Effective in Osteoporosis
2. Implantable Contact Lens Found Safe and Effective
3. Cancer hazard Found With Animal-Based Nutrients
4. Processed Meat, Diabetes connection Found
5. Night Time Aspirin Regimen Found to Reduce Blood Pressure
6. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
7. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
8. Preventive Therapies Found to be More Effective in Managing Migraines
9. Common Cold Found to Fight Cancer
10. Circumcision Found To Prevent HIV Spread
11. Drug Found To Reduce The Transmission Of Herpes
Post Your Comments:

(Date:6/27/2016)... (PRWEB) , ... June 27, ... ... in the patient payment industry today announced its strategic partnership with Connance, ... system workflows. , The two companies’ proven, proprietary technology combine to provide ...
(Date:6/26/2016)... ... 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic treatment ... Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. This ... of the world’s leading providers of cereal and other breakfast foods. Its residents often ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize ... Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into ... Simply select a ProHand generator and drag it above media or text in the ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology and specialty ... Bracket eCOA (SM) 6.0, at the 52 nd ... in Philadelphia , Pennsylvania.  A demonstration of ... its kind to fully integrate with RTSM, will be held ... a flexible platform for electronic clinical outcomes assessments that is ...
Breaking Medicine Technology: